Bausch Health

BHC | NYSE | 0 Followers
$4.67 +0.65% $0.03
Follow
Overview Metrics Financials
Loading...

Fair Price

$3.84
Undervalued by 27.8%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Bausch Health Companies Inc. is a Canadian pharmaceutical company focused on the development and manufacturing of medicines and healthcare products. Originally founded in 1959 as Valeant Pharmaceuticals, the company rebranded as Bausch Health in 2018, shifting its focus to products in ophthalmology, dermatology, dental care, and cardiovascular medicine. Bausch Health specializes in prescription drugs, over-the-counter products, and innovative medical devices, and is known for its strong portfolio in ophthalmology and medical technologies.

Feed

7M
Read More

Bausch Health Cos. Inc.: Billionaire's Bet on Healthcare Conglomerate

Bausch Health Cos. Inc. $BHC, formerly known as Valeant Pharmaceuticals, is attracting the attention of billionaires eyeing the healthcare company's potential for significant growth. BHC owns 88% of its subsidiary Bausch + Lomb $BLCOand has stakes in other companies such as Salix and Solta Medical.

High debt...
Read more
6
Share
Zobrazit další komentáře

The stock is rising very fast and it looks like an interesting investment, but unfortunately the price is pretty high right now.
Like 0
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade